UBS cuts Pacific Biosciences price target to $1.35 from $1.50
UBS cut its price target for Pacific Biosciences to $1.35 per share from $1.50, according to Benzinga ratings actions.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.